Endoscopy 2020; 52(S 01): S132-S133
DOI: 10.1055/s-0040-1704408
ESGE Days 2020 ePoster Podium presentations
Thursday, April 23, 2020 09:30 – 10:00 EUS for lymph nodes ePoster Podium 3
© Georg Thieme Verlag KG Stuttgart · New York

COMBINED EUS-ELASTOGRAPHY (EUS-E) AND CONTRAST-ENHANCED HARMONIC EUS (CH-EUS) IMPROVES DIFFERENTIAL DIAGNOSIS BETWEEN BENIGN AND MALIGNANT LYMPH NODES - A PROSPECTIVE STUDY

A Lisotti
1   Hospital of Imola, Gastroenterology Unit, Imola, Italy
,
A Cominardi
1   Hospital of Imola, Gastroenterology Unit, Imola, Italy
,
M Serrani
1   Hospital of Imola, Gastroenterology Unit, Imola, Italy
,
S Lega
2   Hospital of Imola, Pathology Unit, Imola, Italy
,
S Di Girolamo
3   Hospital of Imola, Oncology Unit, Imola, Italy
,
F Poli
2   Hospital of Imola, Pathology Unit, Imola, Italy
,
L Scopece
3   Hospital of Imola, Oncology Unit, Imola, Italy
,
M Puccetti
2   Hospital of Imola, Pathology Unit, Imola, Italy
,
A Maestri
3   Hospital of Imola, Oncology Unit, Imola, Italy
,
P Fusaroli
1   Hospital of Imola, Gastroenterology Unit, Imola, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

 

Aims To evaluate the diagnostic performance of contrast-enhanced EUS(CH-EUS) and elastography(EUS-E) combination in the differential diagnosis(DD) between benign and malignant lymph nodes(LN).

Methods Consecutive patients with suspected LNs were prospectively enrolled from 2018. EU-ME2 processor(Olympus) elastography and CH-EUS(MI 0.22)with SonoVue(Bracco) were used. Final diagnosis was obtained with pathology(EUS-tissue acquisition or surgical specimen) or based on clinical follow-up(6-month). Age, gender, LN size, location, shape, echotexture, presence of visible vascular hilum. EUS-E, CH-EUS and their combination(both positive, both negative and at least one positive for malignancy) were evaluated.

Results 110 LNs(76 abdominal, 34 mediastinal) in 84 patients(46 male; age 64.8±13.1) were evaluated; of these, 32(29.1%) were benign, 78(70.9%) malignant (65 solid tumor metastasis; 13 lymphoma). No difference was observed in terms of size. B-mode criteria for malignancy were present in 56(50.9%), a visible vascular hilum was identified in 20(18.2%) cases. 54 cases were EUS-E criteria positive, 27 negative and 29 non-diagnostic; 57 cases were CH-EUS criteria positive, 32 negative and 21 non-diagnostic. Vascular hilum identification showed high specificity (97.4%) for benign LNs. [Table 1] showes EUS-E and CH-EUS diagnostic performance. The concordance of the two techniques(both positive) had 100% specificity for malignancy, despite low sensitivity, while when both techniques were negative, specificity for benign LNs was 98.7%. An optimal sensitivity(93.6%) was observed when at least one technique(EUS-elastography “OR” CH-EUS) was suggestive for malignancy.

Tab. 1

Diagnostic performance of EUS-E, CH-EUS and their combination for the DD of suspected LNs

EUS-E

CH-EUS

Both EUS-E “AND”CH-EUS positive for malignancy

EUS-E “OR” CH-EUS positive for malignancy

Sensitivity

69.2%

67.9%

43.6%

93.6%

Specificity

100%

87.5%

100%

87.5%

AUC

0.846

0.777

0.718

0.905